Harnessing the Preconditioning Phenomenon: Does Remote Organ Ischaemia Provide the Answer?
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Despite progress in defining the cellular mechanisms of the ischaemic preconditioning phenomenon, its conversion into convenient clinical practice has been slow. The possibility that an innate mechanism of tissue resistance to ischaemia could be harnessed as a clinical tool is an attractive and enticing prospect.
References
1.
Patel D, Purcell H, Fox K
. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and.... Eur Heart J. 1999; 20(1):51-7.
DOI: 10.1053/euhj.1998.1354.
View
2.
Ikonomidis J, Tumiati L, Weisel R, Mickle D, Li R
. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res. 1994; 28(8):1285-91.
DOI: 10.1093/cvr/28.8.1285.
View
3.
Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A
. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation. 1994; 90(2):700-5.
DOI: 10.1161/01.cir.90.2.700.
View
4.
Heusch G, Schulz R
. Remote preconditioning. J Mol Cell Cardiol. 2002; 34(10):1279-81.
DOI: 10.1006/jmcc.2002.2093.
View
5.
Chen S, Li G, Long L
. [Clinical research of ischemic preconditioning on lung protection]. Hunan Yi Ke Da Xue Xue Bao. 2002; 24(4):357-9.
View